EUVIMEDEUVIMED entdecken
Crossref

Chiral Anthranilic Amides as Potential Cholinesterase Inhibitors: Synthesis, Bioactivity Assessment, and Molecular Modeling

Turgay Tunç, Namık Kılınç, Nadir Demirel, Zuhal Alım iD

Chemistry & Biodiversity · 2025

DOI: 10.1002/cbdv.202500974 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Turgay Tunç und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry Engineering and Process, Faculty of Engineering, University of Kırşehir Ahi Evran, Kırşehir, Türkiye. Hauptthemen laut MEDLINE: Cholinesterase Inhibitors, Amides, Butyrylcholinesterase, Acetylcholinesterase. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Kırşehir Ahi Evran University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inhibitors of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) are central therapeutic targets for Alzheimer's disease (AD). In this study, novel chiral anthranilic amide derivatives ( 5a–5d , 7a , and 7b ) were synthesized from chiral amines and were characterized by 1 H, 13 C NMR, LC–MS, and IR, then inhibitory effect of 5a–5d , 7a , and 7b on AChE/BChE activity was investigated by in vitro inhibition and in silico studies. For AChE, IC 50 values of 5a–5d , 7a , and 7b were found to be 70, 63.64, 53.85, 36.84, 17.07, and 17.5 nM, respectively. For BChE, IC 50 values of 5a–5d , 7a , and 7b were found as 46.66 µM, 33.33 µM, 116.6 µM, 233.3 µM, 175 nM and, 116.6 nM, respectively. All compounds had better inhibition effects against AChE than BChE. The enantioselective inhibition was observed in the compounds 5a–5d . For AChE, the S ‐enantiomers exhibited stronger inhibition than the R ‐enantiomers. However, in the case of BChE, R ‐enantiomers had better inhibition effects. Although molecules 7a and 7b had a stronger inhibition effect than molecules 5a–5d for AChE and BChE, the enantioselectivity was decreased in these molecules. This result was attributed to the spacer group effect in 7a and 7b .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholinesterase InhibitorsAmidesButyrylcholinesteraseAcetylcholinesteraseortho-AminobenzoatesStructure-Activity RelationshipStereoisomerismHumansMolecular StructureModels, MolecularMolecular Docking SimulationDose-Response Relationship, Drug

Stichwörter der Autor:innen

acetylcholinesterasebutyrylcholinesterasechiral anthranilic amideinhibitionmolecular docking

Substanzen

Cholinesterase InhibitorsAmidesButyrylcholinesteraseAcetylcholinesteraseortho-Aminobenzoates

Autor:innen und Institutionen

  • Department of Chemistry Engineering and Process, Faculty of Engineering, University of Kırşehir Ahi Evran, Kırşehir, Türkiye.
  • Department of Medical Services and Techniques, Vocational School of Health Services, University of Iğdır, Iğdır, Türkiye.
  • Department of Chemistry, Faculty of Science and Arts, University of Kırşehir Ahi Evran, Kırşehir, Türkiye.

ORCID-Profile: Zuhal Alım

Förderung

  • Kırşehir Ahi Evran University

Zitieren

APA

Tunç, T., Kılınç, N., Demirel, N., & Alım, Z. (2025). Chiral Anthranilic Amides as Potential Cholinesterase Inhibitors: Synthesis, Bioactivity Assessment, and Molecular Modeling. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202500974

Vancouver

Tunç T, Kılınç N, Demirel N, Alım Z. Chiral Anthranilic Amides as Potential Cholinesterase Inhibitors: Synthesis, Bioactivity Assessment, and Molecular Modeling. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202500974

BibTeX
@article{Tun2025,
  author = {Tunç, Turgay and Kılınç, Namık and Demirel, Nadir and Alım, Zuhal},
  title = {Chiral Anthranilic Amides as Potential Cholinesterase Inhibitors: Synthesis, Bioactivity Assessment, and Molecular Modeling},
  journal = {Chemistry & Biodiversity},
  year = {2025},
  doi = {10.1002/cbdv.202500974}
}
Kostenlos starten →